1. Høivik ML, Moum B, Solberg IC, et al. (2013): Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut 62: 368-375.
2.
Cohen RD, Yu AP, Wu EQ, et al. (2010): Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther 31: 693-707.
3.
Molodecky NA, Soon IS, Rabi DM, et al. (2012): Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142: 46-54.e42; quiz e30.
4.
Ng SC, Shi HY, Hamidi N, et al. (2017): Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390: 2769-2778 [published correction appears in Lancet 2020; 396: e56].
5.
Chi KR (2016): Epidemiology: Rising in the East. Nature 540: S100-S102.
6.
Jostins L, Ripke S, Weersma RK, et al. (2012): Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124.
7.
Frolkis A, Dieleman LA, Barkema HW, et al. (2013): Environment and the inflammatory bowel diseases. Can J Gastroenterol 27: e18-e24.
8.
Ng SC, Bernstein CN, Vatn MH, et al. (2013): Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 62: 630-649.
9.
Peters CP, Mjösberg JM, Bernink JH, et al. (2016): Innate lymphoid cells in inflammatory bowel diseases. Immunol Lett 172: 124-131.
10.
Abraham C, Cho JH (2009): Inflammatory bowel disease. N Engl J Med 361: 2066-2078.
11.
Geremia A, Biancheri P, Allan P, et al. (2014): Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev 13: 3-10.
12.
Kmieć Z, Cyman M, Ślebioda TJ (2017): Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Adv Med Sci 62: 1-16.
13.
Xu XR, Liu CQ, Feng BS, et al. (2014): Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol 20: 3255-3264.
14.
Shiromizu CM, Jancic CC (2018): T Lymphocytes: An effector cell in autoimmunity and infection. Front Immunol 9: 2389.
15.
Vantourout P, Hayday A (2013): Six-of-the-best: unique contributions of T cells to immunology. Nat Rev Immunol 13: 88-100.
16.
Hayday A, Tigelaar R (2003): Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 3: 233-242.
17.
Cheroutre H, Lambolez F, Mucida D (2011): The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 11: 445-456.
18.
Kadivar M, Petersson J, Svensson L, et al. (2016): CD8+ T cells: A novel T cell subset with a potential role in inflammatory bowel disease. J Immunol 197: 4584-4592.
19.
Hayday AC (2000): [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 18: 975-1026.
20.
Dieli F, Troye-Blomberg M, Ivanyi J, et al. (2001): Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis 184: 1082-1085.
21.
Qin G, Mao H, Zheng J, et al. (2009): Phosphoantigen- expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J Infect Dis 200: 858-865.
22.
Andreu-Ballester JC, Catalán-Serra I, Gil-Borrás R, et al. (2020). Gammadelta T cells as a predictor of surgical relapse of Crohn’s disease. Clin Res Hepatol Gastroenterol 44: 586-597.
23.
Zhu T, Zhu L, Sheng C, et al. (2024): Hyperactivation and enhanced cytotoxicity of reduced CD8+ gamma delta T cells in the intestine of patients with Crohn’s disease correlates with disease activity. BMC Immunol 25: 15.
24.
Lo Presti E, Di Mitri R, Mocciaro F, et al. (2019): Characterization of T cells in intestinal mucosa from patients with early-onset or long-standing inflammatory bowel disease and their correlation with clinical status. J Crohns Colitis 13: 873-883.
25.
Jameson JM, Cauvi G, Sharp LL, et al. (2005): Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J Exp Med 201: 1269-1279.
26.
Jameson JM, Sharp LL, Witherden DA, Havran WL (2004): Regulation of skin cell homeostasis by gamma delta T cells. Front Biosci 9: 2640-2651.
27.
Hoffmann JC, Peters K, Henschke S, et al. (2001): Role of T lymphocytes in rat 2,4,6-trinitrobenzene sulphonic acid (TNBS) induced colitis: increased mortality after gammadelta T cell depletion and no effect of alphabeta T cell depletion. Gut 48: 489-495.
28.
Kühl AA, Pawlowski NN, Grollich K, et al. (2007): Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models. J Leukoc Biol 81: 168-175.
29.
Hoffmann JC, Pawlowski NN, Grollich K, et al. (2008): Gammadelta T lymphocytes: a new type of regulatory T cells suppressing murine 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis. Int J Colorectal Dis 23: 909-920.
